The Life Science business of Merck KGaA, Darmstadt, Germany Becomes a Trusted Partner of the Flemingsberg Science Foundation
Flemingsberg, 2025-06-23
The Life Science business of Merck KGaA, Darmstadt, Germany, and Flemingsberg Science Foundation collaborate to promote Life Science sector in Flemingsberg. This strategic partnership aims to strengthen development of ATMP (Advanced Therapy Medicinal Products).
Given the rapid development of ATMP (Advanced Therapy Medicinal Products) in Flemingsberg, the foundation seeks to create a strong support network for individuals and companies within the Life Science sector. Through this partnership with the Life Science business of Merck KGaA, Darmstadt, Germany, Flemingsberg Science Foundation is taking another significant step towards building a robust infrastructure for innovation and growth in the region.
“Together with the foundation and other partners, we will contribute by identifying growth opportunities, infrastructure needs, and investment areas that can further develop the ATMP environment in Flemingsberg. Through our presence in Flemingsberg, we can efficiently and effectively meet the specific needs of companies and organizations within the ATMP sector.” – Gianluca Tagliapietra, Senior VP Commercial SLS EMEA, the Life Science business of Merck KGaA, Darmstadt, Germany.
As a trusted partner, the Life Science business of Merck KGaA, Darmstadt, Germany, will, among other things, organize at least three events per year, become a member of Novum Labs – an innovative environment with state-of-the-art laboratory facilities and room for growth – and host workshops, seminars, and panel discussions on regulatory challenges, commercialization, and scientific advancements.
This partnership is part of the initiative to strengthen the growth and establishment of small and medium-sized enterprises (SMEs) in the life science sector in the Stockholm region.
Johnny Högberg
CEO, stiftelsen Flemingsberg Science
johnny.hogberg@flemingsbergscience.se
070 550 12 73
Merck, a leading science and technology company, operates across life science, healthcare and electronics. More than 62,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2024, Merck generated sales of € 21.2 billion in 65 countries.
Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.
